Core Insights - Kimberly-Clark Corporation reported fourth quarter and full year 2025 results, showcasing momentum from its innovation-driven growth strategy and significant efficiencies that support brand reinvestment and shareholder returns [1][2]. Financial Performance - Fourth quarter net sales were $4.1 billion, down 0.6%, with organic sales growth of 2.1% offset by a 2.5% decline due to exiting the private label diaper business in the US [4][11]. - Gross margin improved to 35.9% from 35.2% year-over-year, with an adjusted gross margin of 37.0%, consistent with the prior year [5][12]. - Operating profit for the quarter was $507 million, up from $420 million, with adjusted operating profit increasing 13.1% to $629 million [6][10]. - Diluted earnings per share (EPS) attributable to Kimberly-Clark were $1.50, a 11.9% increase from the prior year, while adjusted EPS rose 24.0% to $1.86 [10][18]. Yearly Overview - For the full year 2025, net sales totaled $16.4 billion, a decrease of 2.1%, primarily due to divestitures and currency translation impacts [11][12]. - The full year gross margin was 36.0%, down from 37.4% in the previous year, with an adjusted gross margin of 37.3% [12][13]. - Operating profit for the year was $2.4 billion, consistent with the prior year, while adjusted operating profit remained at $2.7 billion [13][24]. - Diluted EPS for the year was $6.07, down from $7.55, but adjusted EPS increased 3.2% to $7.53 [18][39]. Business Segment Results - North America segment net sales decreased 3.0% in Q4, driven by the exit of the private label diaper business, while organic sales growth was 0.8% [21][22]. - International Personal Care segment net sales increased 4.2% in Q4, with organic sales growth of 4.5% [25][26]. - For the full year, North America segment net sales were down 2.4%, while International Personal Care segment net sales decreased 0.9% [22][26]. Cash Flow and Shareholder Returns - Cash provided by operations was $2.8 billion, down from $3.2 billion, with capital spending increasing to $1.1 billion [29]. - The company returned $1.8 billion to shareholders through dividends and share repurchases, completing share repurchases of 1.1 million shares at a cost of $141 million [29]. 2026 Outlook - The company expects organic sales growth in 2026 to align with or exceed the average growth in its competitive categories, forecasting a mid-to-high single-digit growth rate for adjusted operating profit [30]. - Adjusted EPS from continuing operations is anticipated to grow double digits on a constant-currency basis, driven by a projected 30% increase in income from equity companies [30].

Core Insights - Kimberly-Clark Corporation reported third quarter 2025 results driven by resilient consumer demand, innovative product introductions, and effective cost management [1][2][3] Financial Performance - Net sales for Q3 2025 were $4.2 billion, consistent with the prior year, with organic sales increasing by 2.5% due to a 2.4% volume growth [3][11] - Gross margin was reported at 36.0%, with an adjusted gross margin of 36.8%, reflecting a decline of 170 basis points year-over-year due to cost inflation and pricing pressures [4][10] - Operating profit for Q3 was $621 million, with adjusted operating profit at $683 million, remaining in line with the previous year despite challenges [5][12] - Diluted EPS attributable to Kimberly-Clark was $1.34, down from $2.69 in the prior year, while adjusted EPS was $1.82, broadly in line with the previous year [8][15] Year-to-Date Results - For the first nine months of 2025, sales totaled $12.4 billion, a decrease of 2.6%, primarily due to divestitures and foreign currency translation impacts [9][12] - Year-to-date gross margin was 36.0%, with an adjusted gross margin of 37.4%, down 130 basis points compared to the prior year [10][12] - Year-to-date operating profit was $1.8 billion, including $258 million in costs related to the 2024 Transformation Initiative, with adjusted operating profit at $2.1 billion, a decline of 3.2% [12][13] Business Segment Performance - North America net sales decreased by 0.8% in Q3, while organic sales grew by 2.7%, driven by strong volume growth [18][19] - International Personal Care (IPC) net sales increased by 1.9% in Q3, with organic sales growth of 2.1%, reflecting improvements in consumer value propositions [20][21] Cash Flow and Balance Sheet - Year-to-date cash provided by operations was $1.8 billion, down from $2.4 billion last year, attributed to lower operating profit [22][23] - Total debt as of September 30, 2025, was $7.3 billion, a decrease from $7.4 billion at the end of 2024 [23] 2025 Outlook - The company expects 2025 organic sales growth to align with the average growth in its competitive categories, projected at approximately 2% [25][26] - Adjusted operating profit is anticipated to grow at a low single-digit rate on a constant-currency basis, with a negative impact from divestitures and currency translation [26][27] - Adjusted free cash flow is expected to be approximately $2 billion in 2025 [28]

October 28, 2025 Axalta Coating Systems Q3 2025 Financial Results Sensitivity: Business Internal 1 Legal Notices Forward-Looking Statements This presentation and the oral remarks made in connection herewith may contain certain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 regarding Axalta and its subsidiaries including, but not limited to, our outlook and/or guidance, which includes net sales growth, net sales, Adjusted EBITDA, Adjusted Diluted EP ...

Core Insights - Kimberly-Clark Corporation reported strong second quarter results driven by innovation-led volume growth, effective cost management, and resilient consumer demand [1][2][4] - The company is executing its "Powering Care" transformation strategy, which has led to one of the strongest quarters in recent history [2][3] Financial Performance - Net sales for Q2 2025 were $4.2 billion, a decrease of 1.6% from the previous year, impacted by divestitures and foreign currency translation [4][10] - Organic sales increased by 3.9%, primarily due to a 5.0% volume-led growth, partially offset by a 1.2% investment in pricing [4][10] - Gross margin was reported at 35.0%, with an adjusted gross margin of 36.9%, down 180 basis points year-over-year due to pricing pressures and cost inflation [5][10] - Operating profit for Q2 was $592 million, up from $539 million in the prior year, with adjusted operating profit at $713 million, a decline of 2.2% [6][10] Year-to-Date Results - For the first half of 2025, sales totaled $8.2 billion, down 4.0% compared to the same period last year, with organic sales growth of 1.2% [11][12] - Year-to-date gross margin was 36.1%, with an adjusted gross margin of 37.7%, reflecting a decline of 120 basis points year-over-year [12] - Year-to-date operating profit was $1.2 billion, including $196 million in transformation initiative costs, with adjusted operating profit at $1.4 billion, down 4.7% from 2024 [13] Business Segment Performance - North America net sales decreased by 1.9% to $2.7 billion, while organic sales grew by 4.3% driven by strong volume growth [19][20] - International Personal Care (IPC) net sales increased by 0.4% to $1.4 billion, with organic sales growth of 3.3% [21][22] Cash Flow and Balance Sheet - Year-to-date cash provided by operations was $1.1 billion, down from $1.5 billion last year, with capital spending at $401 million [23] - The company returned $944 million to shareholders through dividends and stock repurchases, with total debt at $7.2 billion as of June 30, 2025 [23] 2025 Outlook - The company adjusted its full-year outlook, expecting organic sales growth to outpace the average growth in its categories, which are currently at approximately 2% [24][25] - Adjusted operating profit is anticipated to grow at a low-to-mid single-digit rate on a constant-currency basis, with a negative impact from divestitures and currency translation [26][27] - Adjusted earnings per share are expected to grow at a low-to-mid single-digit rate, factoring in various impacts including higher net interest expense and a higher effective tax rate [27]

Core Insights - Kimberly-Clark Corporation reported a first quarter 2025 net sales of $4.8 billion, a decrease of 6.0% compared to the previous year, impacted by foreign currency translation and divestitures [4][9] - The company adjusted its full-year outlook due to anticipated increased costs from a more uncertain geopolitical landscape, while maintaining confidence in its long-term growth potential [2][21] Financial Performance - Gross margin for the quarter was 35.8%, with an adjusted gross margin of 36.9%, down 20 basis points from the prior year [5][9] - Operating profit was reported at $769 million, down from $853 million in the prior year, with adjusted operating profit at $844 million, reflecting a 6.0% decrease [6][9] - Diluted earnings per share (EPS) were $1.70, down from $1.91 in the prior year, while adjusted EPS decreased 4.0% to $1.93 [8][9] Business Segment Results - North America net sales decreased by 3.9% to $2.7 billion, with organic sales down 0.6% primarily due to price impacts [12][34] - International Personal Care (IPC) net sales fell 8.9% to $1.4 billion, with organic sales down 2.8% driven by price investments [14][35] - International Family Care & Professional (IFP) sales decreased 7.7% to $791 million, with organic sales down 2.3% [16][35] Cash Flow and Balance Sheet - Cash provided by operations was $327 million, down from $438 million, while capital spending increased to $204 million [18][33] - Total debt as of March 31, 2025, was $7.2 billion, a decrease from $7.4 billion at the end of 2024 [18] 2025 Outlook - The company expects organic sales growth in 2025 to outpace the average growth in its categories, with reported net sales forecasted to reflect a negative impact from currency translation and divestitures [20][21] - Adjusted operating profit is now expected to be flat to positive on a constant-currency basis, a revision from previous expectations of high single-digit growth [21][22]